Apertura Gene Therapy Launches Open Aperture, a Material Transfer Agreement Program to Facilitate Non-Commercial Access to TfR1 CapX for Academic Researchers
— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, Feb. 12, 2026 /PRNewswire/ — Apertura... Read more.
Talkiatry Raises Oversubscribed $210M Series D to Expand Nation’s Largest Full-Stack Psychiatry Provider
With more than 800 full-time psychiatrists, Talkiatry strengthens its position as the de facto in-network psychiatry partner for U.S. health systems, payers, and... Read more.
Inovalon Named Global Leaders Champion for Scaling ScriptMed® on Oracle AI Database to Power Pharmacy Operations
Expanded collaboration delivers secure and scalable transaction processing for specialty and infusion pharmacies managing complex therapies BOWIE, Md., Feb. 12,... Read more.
Maestro AI Raises $1.2 Million Pre-Seed Round to Build the Agentic Operating System for Mortgage Origination
Funding to accelerate go-to-market and expand AI-driven automation across the mortgage origination lifecycle PARKLAND, Fla., Feb. 12, 2026 /PRNewswire/ — Maestro... Read more.
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
TAMPA, Fla., Feb. 12, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA” or the “Company”), a Phase 3 immuno-oncology... Read more.
ARTDAI Launches Collection Management Platform for Family Offices
Turn scattered collection records into instant documentation powered by live market analytics and enterprise security NEW YORK, Feb. 12, 2026 /PRNewswire/ —... Read more.
Nova Reports Fourth Quarter and Record Full Year 2025 Results
REHOVOT, Israel, Feb. 12, 2026 /PRNewswire/ — Nova (NASDAQ: NVMI) today announced financial results for the fourth quarter and full year ended December 31,... Read more.
Soligenix Details Recent Progress and Upcoming Milestones
PRINCETON, N.J., Feb. 12, 2026 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on... Read more.
ECARX Announces Fourth Quarter 2025 Unaudited Financial Results
LONDON, Feb. 12, 2026 /PRNewswire/ — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider,... Read more.
ITALY, TRADE SHOWS: KEY 2026, TECHNOLOGIES AND INNOVATIONS FOR CLEAN ENERGY IN RIMINI
KEY 2026 – the Italian Exhibition Group event will be held at the Rimini Exhibition Center from March 4th to 6th with 1,000 exhibiting brands, 32% of which... Read more.